Showing results (211-220 of 280) with videos related to
Sort By:
Pageof 28
IEEE Transactions on Bio-Medical Engineering|September 22, 2020
Photoplethysmographic Waveform Analysis for Autonomic Reactivity Assessment in DepressionSpyridon Kontaxis, Eduardo Gil, Vaidotas Marozas, et al.Aging Clinical and Experimental Research|June 24, 2021
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel diseaseMargalida Calafat, Carlos González-Muñoza, Marta Fortuny, et al.Life Science Alliance|January 15, 2025
UNC119 regulates T-cell receptor signalling in primary T cells and T acute lymphocytic leukaemiaYouhani Samarakoon, Tamas Yelland, Esther Garcia-Gonzalez, et al.European Journal of Nutrition|May 27, 2021
The salivary proteome reflects some traits of dietary habits in diabetic and non-diabetic older adultsChristophe Chambon, Eric Neyraud, Thierry Sayd, et al.Journal of the American Academy of Dermatology|December 29, 2024
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trialsEmma Guttman-Yassky, David Rosmarin, Marjolein de Bruin-Weller, et al.Scandinavian Journal of Gastroenterology|December 1, 2017
Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remissionEsther Garcia-Planella, Míriam Mañosa, María Chaparro, et al.BMC Geriatrics|January 3, 2024
Incidence of urinary incontinence after hip fracture surgery and associated risk factors: a prospective studyMarta Arroyo-Huidobro, Josefa López de la Fuente, Mar Riera Pagespetit, et al.Journal of Crohn'S & Colitis|October 23, 2018
Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative ColitisAriadna Clos-Parals, Paula Rodríguez-Martínez, Fiorella Cañete, et al.The British Journal of Dermatology|September 23, 2025
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage)Richard B Warren, Marjolein de Bruin-Weller, Athanasios Tsianakas, et al.Public Health|January 25, 2025
Intake of fruit, vegetables and pulses, and all-cause, cardiovascular and cancer mortality: Results from a population-based prospective studyPaloma Martínez-Castañeiras, Cristina Ortiz, Nerea Fernandez de Larrea-Baz, et al.Pageof 28